What is BPC-157? — Body Protection Compound Explained
BPC-157 stands for Body Protection Compound-157, a synthetic peptide composed of 15 amino acids. It was first isolated from a naturally occurring protein found in human gastric juice in the early 1990s by researcher Predrag Sikiric.
What makes BPC-157 unique among peptides is its exceptional stability in gastric acid — it remains biologically active for over 24 hours in stomach acid, unlike most peptides that degrade rapidly. This property was discovered during early research and immediately sparked interest in both oral and injectable applications.
The Discovery: From Stomach to Systemic Healing
Researchers originally identified BPC-157 while studying how the body protects and repairs its digestive tract. The 15-amino acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) appeared to play a protective role against gastric ulcers and tissue damage.
But here's where it got interesting: when scientists tested BPC-157 systemically — outside the gut — it showed remarkable effects across multiple tissue types: tendons, ligaments, muscles, joints, and even nerve tissue. Over 700 peer-reviewed studies now document its mechanisms and effects across various injury and inflammation models.
How BPC-157 Works: The Mechanism of Action
BPC-157 operates through multiple interconnected pathways. Understanding these mechanisms helps explain why the peptide has become so popular in regenerative medicine circles:
1. Angiogenesis — New Blood Vessel Formation
BPC-157's primary superpower is stimulating angiogenesis, the formation of new blood vessels. It does this by upregulating vascular endothelial growth factor (VEGF) and other angiogenic signaling pathways.
Why does this matter? Tendons and ligaments are famously poorly vascularized — they get weak blood supply, which is why they heal so slowly. By triggering new capillary formation, BPC-157 dramatically improves oxygen and nutrient delivery to damaged tissue, accelerating the entire repair cascade.
2. Collagen Synthesis & Extracellular Matrix Remodeling
The peptide stimulates fibroblast activity, the cells responsible for producing collagen — the structural foundation of tendons, ligaments, cartilage, and skin. More importantly, it promotes type I collagen synthesis (the strong, organized form) rather than type III (the weaker, disorganized form often produced during scar formation).
This distinction is critical: healed tissue that contains properly organized type I collagen is stronger and more resilient than tissue repaired without BPC-157, which tends to accumulate type III collagen and fibrosis.
3. Anti-Inflammatory Signaling (Balanced, Not Suppressed)
BPC-157 doesn't just reduce inflammation — it rebalances it. The peptide:
- Downregulates pro-inflammatory cytokines (TNF-α, IL-6)
- Reduces COX-2 expression and myeloperoxidase activity
- Suppresses excessive nitric oxide production (which damages tissue during chronic inflammation)
- Shifts macrophages toward an M2 reparative phenotype
Critically, it preserves the short-term inflammatory response needed for healing to occur. This is different from NSAIDs or corticosteroids, which broadly suppress inflammation and can actually slow recovery.
4. Growth Factor & Cellular Signaling
BPC-157 influences multiple growth factor pathways involved in tissue regeneration, including:
- Growth hormone receptor upregulation
- Focal adhesion kinase (FAK) activation
- Nitric oxide pathway enhancement
- Gene expression favoring cellular repair
This multi-pathway approach is why BPC-157 works across so many different tissue types.
BPC-157 Benefits — What Research Actually Shows
Free Resource
Get the free Peptide Starter Guide
BPC-157, Semaglutide, TB-500, GHK-Cu, Thymosin Alpha-1 — what the research says and how to source safely. Straight to your inbox.
🔒 No spam. Unsubscribe anytime.
1. Tendon & Ligament Healing (Strongest Evidence)
This is where BPC-157 shines. Tendon and ligament injuries are notoriously difficult to treat because these tissues have poor blood supply and heal slowly under normal conditions.
What the research shows:
- Animal studies on Achilles tendon ruptures show accelerated healing with improved tensile strength when BPC-157 is administered near the injury site
- Ligament repair studies demonstrate faster collagen organization and stronger structural integrity
- Recovery timelines reduced by approximately 30–50% in animal models, with improvements visible within 2–4 weeks
Clinical relevance: Athletes and active individuals report significant improvements in:
- Achilles tendonitis
- Rotator cuff tears
- ACL/MCL injuries
- Patellar tendonitis
- Ankle sprains and chronic ankle instability
- Tennis elbow and golfer's elbow
Real-world timeline: Most users report noticeable pain reduction within 1–2 weeks, with substantial functional improvement by week 4–6. Full structural repair typically requires 8–12 weeks.
2. Gut Healing & Leaky Gut (Strongest Clinical Evidence)
This is BPC-157's original application, and it's where human clinical evidence is most robust. The peptide was discovered in gastric juice specifically for its role in protecting and repairing the digestive lining.
What the research shows:
- NSAID-induced damage: Multiple studies confirm BPC-157 restores the stomach lining after aspirin or ibuprofen exposure
- Gastric ulcers: Significant reduction in ulcer formation and acceleration of ulcer healing
- Leaky gut (intestinal permeability): BPC-157 restores tight junction integrity by upregulating claudin, occludin, and zonulin — the proteins that seal spaces between intestinal cells
- IBD (Crohn's & Ulcerative Colitis): Animal models show reduced intestinal inflammation, improved barrier function, and reduced secondary damage
Mechanism in the gut:
- Enhances epithelial cell regeneration
- Restores tight junction protein expression
- Reduces pro-inflammatory cytokine production in gut-associated lymphoid tissue
- Promotes angiogenesis to improve mucosal blood supply
Real-world timeline for gut issues:
- Acute gastric ulcers/NSAID damage: 1–2 weeks for noticeable improvement
- Leaky gut/chronic inflammation: 4–8 weeks for meaningful restoration of barrier function
- IBD: 8–12+ weeks with ongoing benefit accumulation
3. Muscle Recovery & Post-Workout Repair
BPC-157 appears to accelerate muscle protein synthesis and reduce exercise-induced inflammation, though human evidence is still emerging.
What research suggests:
- Enhanced satellite cell activation (muscle repair cells)
- Accelerated removal of damaged muscle fibers
- Reduced delayed-onset muscle soreness (DOMS)
- Faster return to baseline strength after intense training
4. Joint Health & Arthritis Relief
BPC-157's anti-inflammatory and tissue-regenerative effects extend to joint tissue.
Effects documented:
- Reduced synovial inflammation (the fluid that lubricates joints)
- Cartilage matrix preservation (early research)
- Decreased joint pain and improved range of motion
- Benefits for both osteoarthritis (wear-and-tear) and post-inflammatory joint dysfunction
5. Neuroprotection & Nerve Repair (Emerging)
Emerging research suggests BPC-157 may support nervous system recovery through:
- Neuronal survival enhancement
- Synaptic plasticity support
- Nerve regeneration in peripheral nerves
- Potential neuroprotective effects against oxidative stress
6. Vascular Health & Circulation
By stimulating angiogenesis, BPC-157 appears to improve microvascular circulation, endothelial function, recovery from vascular injuries, and general tissue oxygenation.
BPC-157 for Gut Health — Deep Dive
Since "BPC-157 for gut health" drives massive search volume, this section deserves its own treatment.
The Leaky Gut Connection
Leaky gut (intestinal hyperpermeability) occurs when tight junction proteins break down, allowing undigested food particles, bacterial toxins, and lipopolysaccharides to translocate into the bloodstream. This triggers systemic inflammation, immune activation, and a cascade of downstream issues:
- Food sensitivities and allergies
- Autoimmune activation
- Brain fog and cognitive dysfunction
- Skin issues (rashes, acne, eczema)
- Joint pain
- Chronic fatigue
BPC-157 directly addresses the root cause: it restores tight junction protein expression and function.
BPC-157 is the only peptide with direct human gastric juice origins. It wasn't designed to heal the gut — it was found there, doing it naturally.
Oral vs. Injectable for Gut Health
For gut-specific applications, oral BPC-157 is often preferred because:
- The peptide reaches the damaged gut tissue directly
- Oral delivery doesn't require needles (better compliance)
- Local concentration in the GI tract is high
- Studies confirm oral BPC-157 (given in drinking water in rats) produces measurable gut healing effects
Dosing for gut health (oral):
- 250–500 mcg per day, often split into two doses
- Some protocols use up to 1,000 mcg twice daily for severe conditions
- Duration: 4–8 weeks for acute damage; 8–12+ weeks for chronic conditions
- Best taken on an empty stomach for maximum absorption
Conditions That Respond Well to BPC-157
| Condition | Evidence Level | Typical Timeline | Notes |
|---|---|---|---|
| NSAID-induced ulcers | Strong | 1–2 weeks | Protective and healing both |
| Gastric ulcers | Strong | 2–4 weeks | Faster than standard PPIs reported |
| Leaky gut | Good | 4–8 weeks | Restores tight junction function |
| Crohn's disease | Good (animal) | 8–12 weeks | Often stacked with dietary changes |
| Ulcerative colitis | Good (animal) | 8–12 weeks | Reduces inflammation and bleeding |
| IBS | Limited | 4–8 weeks | Works better if inflammation is present |
| Chronic gastritis | Good | 4–8 weeks | Reduces pain and inflammation |
| Food sensitivities | Anecdotal | 6–10 weeks | Improves as barrier function restores |
Dosing Protocols — The Complete Guide
IMPORTANT: The following represents commonly used protocols from the regenerative medicine community. Individual needs vary. Medical supervision is strongly recommended.
Dosing Formula by Body Weight (Injectable)
The research standard is 1–10 mcg per kilogram (mcg/kg) of body weight, which translates to:
| Body Weight | Low Dose | Standard Dose | High Dose |
|---|---|---|---|
| 150 lbs (68 kg) | 68 mcg | 250–340 mcg | 500–680 mcg |
| 175 lbs (79 kg) | 79 mcg | 250–400 mcg | 500–790 mcg |
| 200 lbs (91 kg) | 91 mcg | 250–455 mcg | 500–910 mcg |
| 225 lbs (102 kg) | 102 mcg | 300–500 mcg | 600–1,020 mcg |
Most common protocol: 250–500 mcg once or twice daily (regardless of exact weight).
Injection Administration
Route: Subcutaneous (under the skin) or intramuscular (into muscle)
Best injection sites:
- Abdomen (systemic healing)
- Thigh (systemic healing)
- Near injury site (localized healing — e.g., around a damaged tendon)
Injection frequency:
- Daily or every other day for 4–8 weeks
- Some protocols use twice-daily dosing for acute injuries
- A 1–2 week break between cycles is common
Reconstitution:
- Obtain lyophilized (freeze-dried) BPC-157 powder (typically 5–10mg per vial)
- Reconstitute with bacteriostatic water (0.9% sodium chloride + benzyl alcohol)
- Store reconstituted solution at 2–8°C (refrigerator)
- Use within 2–3 weeks of reconstitution (stability degrades)
- Draw into an insulin syringe (31-gauge, 1mL)
Injection site rotation: Change injection sites with each dose to minimize tissue irritation and lipodystrophy (fat deposits).
Oral Dosing (Capsules)
Typical protocols:
- 250–500 mcg once or twice daily for general use
- 500–1,000 mcg twice daily for gut-specific conditions
- Taken on an empty stomach (30 minutes before food, 2+ hours after)
- Duration: 4–8 weeks, with a 1–2 week break before restarting
Why higher oral doses? Oral bioavailability is 3–30% depending on formulation. Arginine salt formulations claim higher bioavailability (~90%), but this remains unconfirmed in human studies.
Oral vs. Injectable BPC-157 — The Complete Comparison
| Factor | Injectable | Oral |
|---|---|---|
| Bioavailability | 80–95% | 3–90% (depending on form) |
| Onset | 1–2 weeks | 2–4 weeks |
| Best for | Tendon/ligament/muscle/joint injuries | Gut health, systemic support, convenience |
| Dosing | 250–500 mcg daily | 500–1,000 mcg twice daily |
| Needle required | Yes | No |
| Cost | ~$150–400/month (clinic) | ~$50–150/month |
| Precision | High (targeted injection) | Lower (variable absorption) |
| Research support | Strongest | Growing but limited in humans |
When to Use Oral vs. Injectable
Inject if:
- You have a specific musculoskeletal injury (tendon, ligament, muscle, joint)
- You want faster results
- You're willing to use needles
- You want predictable dosing
Use oral if:
- Your primary goal is gut health
- You have needle phobia
- You prefer convenience
- You want to maintain BPC-157 long-term without injections
- You're using it for general systemic inflammation
Consider both if: You're addressing both a gut issue AND a musculoskeletal injury — many clinicians use oral for gut healing + injections near the injury site for dual benefits.
How Long Does BPC-157 Take to Work?
Realistic timeline expectations:
| Timeframe | What to Expect |
|---|---|
| Days 1–7 | Subtle changes in pain or discomfort; nothing dramatic |
| Weeks 2–3 | Noticeable reduction in pain and inflammation; improved mobility |
| Weeks 4–6 | Significant functional improvement; most users report this as "the turning point" |
| Weeks 8–12 | Substantial tissue repair; marked improvement in strength and range of motion |
| Weeks 12+ | Continued remodeling; full structural integrity restoration (for significant injuries) |
Important caveat: Individual variation is huge. Factors affecting timeline: age, injury severity, overall health and nutrition, sleep quality, concurrent training/rehabilitation, and dosing consistency.
BPC-157 Stacking Protocols — Peptide Combinations
Stack #1: BPC-157 + TB-500 (The "Wolverine Stack")
Goal: Comprehensive connective tissue healing
Why this combination works:
- BPC-157 drives angiogenesis and anti-inflammatory effects
- TB-500 (Thymosin Beta-4) promotes cell migration and actin remodeling
- Together they address different phases of the healing cascade
Protocol:
- BPC-157: 250–500 mcg daily (subcutaneous)
- TB-500: 2–5 mg twice weekly (subcutaneous)
- Duration: 8–12 weeks
Users report faster pain relief + more complete tissue regeneration vs. either peptide alone. For a full TB-500 protocol breakdown, see our TB-500 guide (coming soon).
Stack #2: BPC-157 + CJC-1295/Ipamorelin (Growth Hormone Enhancement)
Goal: Tissue repair + systemic recovery + sleep/body composition benefits
Protocol:
- BPC-157: 250–500 mcg daily
- CJC-1295: 100 mcg (1x per week)
- Ipamorelin: 100–200 mcg daily (evening)
- Duration: 12–16 weeks
Why it works: Growth hormone amplifies collagen synthesis and cellular regeneration, stacking on top of BPC-157's direct healing effects.
Stack #3: BPC-157 + KPV (Gut Healing Powerhouse)
Goal: Maximum gut lining repair
Protocol:
- BPC-157: 250–500 mcg daily (oral)
- KPV: 250–500 mcg daily (oral)
- Duration: 8–12 weeks
Why: KPV targets inflammation; BPC-157 targets tissue repair. Different mechanisms = synergistic effects in the GI tract. See our BPC-157 + KPV gut healing stack guide for the full protocol.
Note: No published studies on stacking combinations — these protocols are based on mechanistic rationale and community experience.
Side Effects & Safety Profile
What Research Shows
In animal studies (6+ weeks at high doses):
- No toxicity observed across liver, kidneys, prostate, ovaries, brain, or lungs
- No behavioral abnormalities
- No weight loss or organ damage
- Excellent tolerability even at doses 10–20× typical therapeutic doses
Reported Side Effects (Human Use)
Rare but possible:
- Injection site reactions: Mild redness, soreness (common with all subcutaneous injections)
- Nausea: Occasional, usually mild
- Dizziness: Rare
- Headache: Very rare
- Allergic reactions: Extremely rare; watch for rash or respiratory symptoms
Safety Considerations
Who should avoid BPC-157:
- Pregnant or breastfeeding women (insufficient human data)
- Anyone with active cancer (theoretical concern about promoting angiogenesis in tumors; not confirmed in humans)
- Those with known peptide allergies
Contraindications to discuss with your provider:
- Immunosuppressive therapy
- Uncontrolled diabetes
- Severe cardiovascular disease
- Undiagnosed conditions
Drug Interactions
No major drug interactions documented, but always inform your provider if you're taking NSAIDs, corticosteroids, blood thinners, or any prescription medications.
Is BPC-157 Legal? — Regulatory Status [2026 Update]
⚡ Major 2026 Regulatory Development: On April 15, 2026, the FDA removed BPC-157 from its Category 2 restricted list. A formal Pharmacy Compounding Advisory Committee meeting is scheduled for July 23–24, 2026 to evaluate BPC-157 for permanent inclusion on the Section 503A Bulk Drug Substances List.
Current legal status (April 2026):
- Not FDA-approved for any indication
- Available through compounding pharmacies in most states (with a clinical prescription)
- Sold as "research chemical" on some websites (use caution with quality)
- WADA banned for competitive sports (listed as S0 "Unapproved Substance")
If you choose to use BPC-157:
- Work with a licensed healthcare provider
- Obtain from a licensed compounding pharmacy (highest quality assurance)
- Avoid black-market or "research chemical" vendors
- Verify third-party testing and Certificate of Analysis (COA)
For the full context on recent FDA regulatory changes, see our FDA Peptide Update 2026 article.
How to Source Quality BPC-157
Red Flags (Avoid These)
- No Certificate of Analysis (COA)
- Claims of "99.9% pure" without third-party verification
- Suspiciously low prices
- Vague company information or no verifiable contact
- Reconstituted powder (should be lyophilized)
- No batch tracking or traceability
Green Flags (What to Look For)
- Third-party COA from independent lab (HPLC verified, mass spec confirmed)
- Pharmaceutical-grade manufacturing standards
- Lyophilized powder (not pre-reconstituted)
- Proper storage requirements documented
- Batch number and expiration date clearly labeled
- Refrigerated shipping for pre-reconstituted forms
- Licensed compounding pharmacy or established supplier
Where to source: See our curated supplier picks →
Purity Standards to Verify
- Minimum acceptable purity: 95%
- Preferred purity: 98%+
- HPLC verification: Required
- Mass spectrometry confirmation: Strongly recommended
- Endotoxin testing: Critical if injectable
Reconstitution Guide — Injectable BPC-157
What You'll Need
- BPC-157 lyophilized powder (typically 5–10mg per vial)
- Bacteriostatic water (0.9% sodium chloride + benzyl alcohol preservative)
- Insulin syringes (31-gauge, 1mL)
- Alcohol wipes (for sanitizing)
- Sharps container (for safe needle disposal)
For a complete walkthrough, see our peptide reconstitution guide.
Step-by-Step Reconstitution
1. Calculate your dilution
- If you have 10mg BPC-157 powder and want 250 mcg/mL solution: add 40mL bacteriostatic water. Each 1mL = 250 mcg.
- Most people dilute to 250–500 mcg/mL for easier dosing
2. Clean the vial
- Wipe the rubber stopper with an alcohol wipe and let air dry
3. Draw bacteriostatic water
- Fill an insulin syringe with the calculated amount of bacteriostatic water and inject slowly into the BPC-157 vial
4. Reconstitute gently
- Do NOT shake vigorously (can denature the peptide)
- Gently roll the vial between your palms until powder is fully dissolved
- Solution should be clear and colorless. Do NOT use if cloudy or discolored
5. Storage
- Store reconstituted BPC-157 at 2–8°C (refrigerator)
- Use within 2–3 weeks of reconstitution
- Do NOT freeze. Label with reconstitution date and concentration
BPC-157 vs. TB-500 vs. GHK-Cu — The Comparison
| Factor | BPC-157 | TB-500 | GHK-Cu |
|---|---|---|---|
| Best for | Tendon/ligament/gut | Connective tissue + flexibility | Skin health + collagen |
| Mechanism | Angiogenesis + collagen synthesis | Cell migration + actin remodeling | Collagen signaling + wound healing |
| Onset | 2–4 weeks | 2–4 weeks | 4–6 weeks |
| Gut healing | Strongest | Weak | Weak |
| Tendon repair | Strong | Very strong | Moderate |
| Skin improvement | Weak | Moderate | Strong |
| Dosing | 250–500 mcg daily | 2–5 mg weekly | 500 mcg–2 mg daily |
| Oral form | Yes (arginine salt) | No | No |
| Stacking | Goes with both | Goes with BPC-157 | Works standalone or with BPC-157 |
For a detailed GHK-Cu protocol breakdown, see our GHK-Cu Complete Guide.
Related WellSourced Articles
- Glutathione: The Body's Master Antioxidant and Longevity Molecule — BPC-157 and glutathione are often stacked for comprehensive cellular protection and gut healing
- The Tripeptide Your Liver Begs For After a Night Out — How glutathione and BPC-157 together address alcohol-induced gut and oxidative damage
- The Gut-Peptide Connection: BPC-157 + KPV — Deep dive on the most powerful oral gut healing combination
- FDA Peptide Update 2026 — Full context on BPC-157's removal from the restricted list
FAQ — BPC-157 Common Questions
Is BPC-157 legal?
BPC-157 is not FDA-approved for human use, but as of April 2026, it's no longer on the FDA's Category 2 restricted list. Licensed compounding pharmacies can fill prescriptions. It's banned in competitive sports (WADA S0 substance). Always source from reputable compounding pharmacies and work with a licensed provider.
How long does BPC-157 take to work?
Most users report noticeable improvement within 2–4 weeks, with significant benefits by week 6–8. For tendon/ligament injuries, pain typically decreases first (1–2 weeks), followed by functional improvement (4–6 weeks). Full structural repair may take 8–12+ weeks.
Can you take BPC-157 orally?
Yes. Oral BPC-157 is especially effective for gut health because it reaches the digestive tract directly. For musculoskeletal injuries, injectable forms are superior due to higher bioavailability (80–95% injectable vs. 3–90% oral). Oral capsules use arginine salt formulations for better absorption.
What does BPC-157 do?
BPC-157 stimulates angiogenesis (new blood vessel formation), collagen synthesis, and anti-inflammatory signaling. This accelerates healing of tendons, ligaments, muscles, joints, and the gut lining. It works by balancing inflammation (not suppressing it) and promoting tissue regeneration at the cellular level.
What is BPC-157 good for?
BPC-157 is most researched for:
- Tendon and ligament injuries (strongest evidence)
- Gut healing (leaky gut, ulcers, IBS, Crohn's)
- Joint pain and arthritis (emerging evidence)
- Muscle recovery (anecdotal + animal data)
- Post-surgical healing (growing clinical use)
Is BPC-157 safe?
Animal studies show excellent safety with minimal side effects even at high doses. Most users tolerate it well. Rare side effects include mild nausea or injection site soreness. It's not recommended during pregnancy/breastfeeding or for people with active cancer. Always consult a healthcare provider before use.
How much BPC-157 should I take?
- Injectable: 250–500 mcg daily (1–10 mcg/kg body weight)
- Oral: 500–1,000 mcg daily for general use; up to 1,000 mcg twice daily for gut conditions
- Dosing depends on body weight, injury severity, and goals. Work with a provider for personalized protocols.
Is BPC-157 an anabolic steroid?
No. BPC-157 is a peptide (short chain of amino acids), not a steroid. It doesn't alter testosterone or other hormones. It works through growth factor signaling and tissue repair pathways, not hormonal manipulation.
What is the BPC-157 cycle length?
Typical cycle: 4–8 weeks for acute injuries; 8–12+ weeks for chronic conditions. Most protocols include a 1–2 week break between cycles to allow the body to return to baseline.
Conclusion: BPC-157 as a Healing Tool
BPC-157 represents a genuine advance in tissue regeneration science. Unlike traditional approaches that mask symptoms (NSAIDs, steroids) or provide temporary relief (physical therapy alone), BPC-157 works to address the biological foundation of healing by improving blood flow, promoting collagen synthesis, and rebalancing inflammation.
The strongest evidence supports:
- Tendon and ligament repair (compelling animal data, growing clinical use)
- Gut lining restoration (multiple animal models, extensive research)
- General tissue regeneration (broad mechanism across tissue types)
The honest limitations:
- Limited human clinical trials (most evidence comes from animal models)
- Not FDA-approved (regulatory pathway ongoing as of 2026)
- Long-term safety in humans not fully established
- Individual results vary significantly
If you're managing a real injury or chronic condition, BPC-157 paired with proper rehabilitation, nutrition, sleep, and stress management offers a comprehensive approach to recovery that most users find worthwhile.
The peptide is not a shortcut — it's a tool that works with your body's natural healing mechanisms, not against them.